PN,30301
SC,0001
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,FScientists have developed a new test
OL,7,Ffor certain breast cancer patients
OL,8,Fwhich can predict whether or not their
OL,9,Fcancer is likely to return just two
OL,10,Fweeks after they start treatment.
OL,12,FExperts said thousands of breast
OL,13,Fcancer patients could be spared
OL,14,Funnecessary treatment as a result.
OL,1,W~k4~sj5j5~s1G                    G1/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30302
SC,0002
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,FThe new test has been devised to
OL,7,Fdetect the likelihood of cancer
OL,8,Freoccurring in patients with a type of
OL,9,Fbreast cancer known as oestrogen
OL,10,Freceptor positive, human epidermal
OL,11,Fgrowth factor receptor 2 positive `
OL,12,Fwhich accounts for around 200,000
OL,13,Fcases of cancer each year around the
OL,14,Fglobe.
OL,16,FWriting in the journal eBioMedicine,
OL,17,Fexperts said the test means that some
OL,18,Fpatients will be able to "de-escalate"
OL,19,Ftheir treatment while it could also
OL,20,Fhelp identify those who need "more
OL,21,Fintensive therapeutic strategies".
OL,26,@zD@ZOUzD@fO]|D@^OU}D@aO]
OL,1,W~k4~sj5j5~s1G                    G2/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30303
SC,0003
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,FThe test, which was developed by
OL,7,Fscientists at The Institute for Cancer
OL,8,FResearch, London, correctly identifies
OL,9,Fthe 6% of patients at highest risk of
OL,10,Frelapse.
OL,12,FResearchers analysed tumour samples
OL,13,Ffrom 213 patients.
OL,15,FThey found that two weeks of hormone
OL,16,Ftherapy changes the characteristics of
OL,17,Fsome tumours, causing them to shift
OL,18,Ftheir subtype.
OL,1,W~k4~sj5j5~s1G                    G3/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30304
SC,0004
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,FThe patients with the highest risk of
OL,7,Fcancer returning had a type of tumour
OL,8,Fcalled Luminal B that did not change
OL,9,Fafter this short-term hormone therapy.
OL,11,FExperts said these patients will
OL,12,Frequire more intensive treatment.
OL,14,FThey said the findings highlight the
OL,15,Fbenefit of two weeks of hormone
OL,16,Ftherapy before surgery to help guide
OL,17,Fdoctors' decision making.
OL,1,W~k4~sj5j5~s1G                    G4/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30305
SC,0005
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,FCorresponding author of the study, Dr
OL,7,FMaggie Cheang, from The Institute of
OL,8,FCancer Research, London, said: "To
OL,9,Fdeliver truly personalised care, we
OL,10,Fneed to refine how we classify breast
OL,11,Fcancer, so that each patient receives
OL,12,Fthe treatment most likely to benefit
OL,13,Fthem.
OL,15,F"While current classification relies
OL,16,Fon hormone receptor and HER2 status,
OL,17,Fwe know that patients within these
OL,18,Fgroups can respond very differently to
OL,19,Fthe same therapy.
OL,26,@pD@`OUwD@AOU
OL,1,W~k4~sj5j5~s1G                    G5/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30306
SC,0006
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,F"Our earlier research identified
OL,7,Fdistinct molecular subtypes within
OL,8,FHER2-positive, oestrogen receptor-
OL,9,Fpositive breast cancer. In this new
OL,10,Fstudy, we've shown that these subtypes
OL,11,Fcan shift after just two weeks of
OL,12,Fhormone therapy.
OL,14,F"This insight helps us identify which
OL,15,Fpatients are likely to respond well
OL,16,Fand which may show early signs of
OL,17,Ftreatment resistance, offering the
OL,18,Fopportunity to tailor treatment
OL,19,Fstrategies sooner.
OL,26,@nD@AOUvD@AOU
OL,1,W~k4~sj5j5~s1G                    G6/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30307
SC,0007
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,F"Ultimately, our findings move us
OL,7,Fcloser to more precise, patient-
OL,8,Fcentred care for this overlooked
OL,9,Fbreast cancer subtype."
OL,11,FProfessor Kristian Helin, chief
OL,12,Fexecutive of The Institute of Cancer
OL,13,FResearch, London, added: "By decoding
OL,14,Fthe underlying biology of tumours, we
OL,15,Fcan tailor treatments to individual
OL,16,Fpatients."
OL,26,@nD@AOUqD@WO]uD@ZOUxD@JO]
OL,1,W~k4~sj5j5~s1G                    G7/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30308
SC,0008
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,FDr Simon Vincent, chief scientific
OL,7,Fofficer at Breast Cancer Now, which
OL,8,Fpart-funded the study, said: "These
OL,9,Ffindings add to the growing evidence
OL,10,Fthat genomic testing can play a
OL,11,Fpowerful role in helping to predict
OL,12,Fthe risk of a woman's breast cancer
OL,13,Fcoming back, particularly in people
OL,14,Fwith ER-positive, HER2-positive breast
OL,15,Fcancer.
OL,26,@pD@^OU
OL,1,W~k4~sj5j5~s1G                    G8/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
PN,30309
SC,0009
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F303A1752891189
OL,3,CNew test could revolutionise aftercare
OL,4,Cfor thousands of breast cancer patients
OL,6,F"There's potential for women to
OL,7,Fbenefit hugely from this research in
OL,8,Fthe future, with it ensuring they
OL,9,Favoid undergoing unnecessary treatment
OL,10,Fand leading to more personalised
OL,11,Ftreatment plans, so that women receive
OL,12,Fthe most effective therapy for their
OL,13,Fspecific type of breast cancer."
OL,26,@nD@AOUuD@`O]
OL,1,W~k4~sj5j5~s1G                    G9/9
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,304,300,200,140,000,100
